152 related articles for article (PubMed ID: 3090107)
1. Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus.
Bareford D; Jennings PE; Stone PC; Baar S; Barnett AH; Stuart J
J Clin Pathol; 1986 Jul; 39(7):722-7. PubMed ID: 3090107
[TBL] [Abstract][Full Text] [Related]
2. myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.
Popp-Snijders C; Lomecky-Janousek MZ; Schouten JA; van der Veen EA
Diabetologia; 1984 Nov; 27(5):514-6. PubMed ID: 6439588
[TBL] [Abstract][Full Text] [Related]
3. Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus.
Robey C; Dasmahapatra A; Cohen MP; Suarez S
Diabetes; 1987 Sep; 36(9):1010-3. PubMed ID: 3609495
[TBL] [Abstract][Full Text] [Related]
4. Role of red cell sorbitol as determinant of reduced erythrocyte filtrability in insulin-dependent diabetics.
Carandente O; Colombo R; Girardi AM; Margonato A; Pozza G
Acta Diabetol Lat; 1982; 19(4):359-68. PubMed ID: 6758460
[TBL] [Abstract][Full Text] [Related]
5. The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients.
Airey CM; Price DE; Kemp JV; Perkins CM; Wales JK
Diabet Med; 1989 Dec; 6(9):804-8. PubMed ID: 2533041
[TBL] [Abstract][Full Text] [Related]
6. Effect of statil (ICI 128436) on erythrocyte viscosity in vitro.
Rillaerts EG; Vertommen JJ; De Leeuw IH
Diabetes; 1988 Apr; 37(4):471-5. PubMed ID: 3378686
[TBL] [Abstract][Full Text] [Related]
7. Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus.
Cunningham JJ; Mearkle PL; Brown RG
J Am Coll Nutr; 1994 Aug; 13(4):344-50. PubMed ID: 7963139
[TBL] [Abstract][Full Text] [Related]
8. Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy.
Kowluru R; Bitensky MW; Kowluru A; Dembo M; Keaton PA; Buican T
Proc Natl Acad Sci U S A; 1989 May; 86(9):3327-31. PubMed ID: 2541440
[TBL] [Abstract][Full Text] [Related]
9. Effects of glucose and SNK-860, an aldose reductase inhibitor, on the polyol pathway and chemiluminescence response of human neutrophils in vitro.
Kawamura T; Suzuki K; Matsumae H; Sano T; Sakamoto N; Hotta N
Diabet Med; 1995 May; 12(5):392-6. PubMed ID: 7648800
[TBL] [Abstract][Full Text] [Related]
10. Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients.
Asano T; Saito Y; Kawakami M; Yamada N;
J Diabetes Complications; 2002; 16(2):133-8. PubMed ID: 12039395
[TBL] [Abstract][Full Text] [Related]
11. Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes.
Martyn CN; Matthews DM; Popp-Snijders C; Tucker J; Ewing DJ; Clarke BF
Diabetes Care; 1986; 9(1):36-9. PubMed ID: 3948646
[TBL] [Abstract][Full Text] [Related]
12. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients.
Hamada Y; Kitoh R; Raskin P
Diabetes; 1991 Oct; 40(10):1233-40. PubMed ID: 1936586
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects.
Malone JI; Leavengood H; Peterson MJ; O'Brien MM; Page MG; Aldinger CE
Diabetes; 1984 Jan; 33(1):45-9. PubMed ID: 6690344
[TBL] [Abstract][Full Text] [Related]
15. Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus.
Wang H; Zhang ZB; Wen RR; Chen JW
Diabetes Res Clin Pract; 1995 Apr; 28(1):1-8. PubMed ID: 7587907
[TBL] [Abstract][Full Text] [Related]
16. Improvement in peripheral nerve function after one year of Sorbinil.
Gieron MA; Malone JI; Lowitt S; Korthals JK
Neuroreport; 1991 Jun; 2(6):348-50. PubMed ID: 1655107
[TBL] [Abstract][Full Text] [Related]
17. Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent.
Morrisey K; Steadman R; Williams JD; Phillips AO
Kidney Int; 1999 Jan; 55(1):160-7. PubMed ID: 9893124
[TBL] [Abstract][Full Text] [Related]
18. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
[TBL] [Abstract][Full Text] [Related]
19. [Reduction of erythrocyte sorbitol by ascorbic acid in patients with diabetes mellitus].
Wang H; Zhang ZB; Wen RR
Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):548-51, 583. PubMed ID: 7842354
[TBL] [Abstract][Full Text] [Related]
20. Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. II. Characterization of high- and low-affinity myo-inositol transport sites.
Cammarata PR; Chen HQ; Yang J; Yorio T
Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3572-80. PubMed ID: 1464503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
